SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET

Send Inquiry

Request To Call Back

SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET

Name: SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET
Brand: SKYOGEN HEALTHCARE LIMITED
Price: 55.0 INR
Availability: InStock

Price 55.0 INR/ Piece

Get a Price/Quote

MOQ : 100 Pieces

SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET Specification

Life Span
36 months (typical) from manufacturing date.

Origin of Medicine
India

Packaging Type
Blister strip

Salt Composition
Sodium Valproate 333 mg + Valproic Acid 145 mg

Brand Name
Not specified in image, typically manufacturer dependent.

Pacakaging (Quantity Per Box)
10x10 tablets (varies depending on manufacturer).

Indication
Indicated for the treatment of epilepsy, prevention of seizures, and bipolar disorder.

Dosage Form
Controlled release tablet

Drug Type
Allopathic

Ingredients
Each tablet contains Sodium Valproate 333 mg and Valproic Acid 145 mg (controlled release).

Physical Form
Tablets

Function
Anticonvulsant, mood stabilizer.

Recommended For
Epilepsy, bipolar disorder, and other neurological conditions as prescribed by a physician.

Dosage
As directed by the physician. Typical adult dose: adjust based on clinical response.

Dosage Guidelines
Swallow whole, do not crush or chew. Take after meals to minimize gastric irritation.

Suitable For
Adults and children above 12 years, as directed by a doctor.

Quantity
Varies (commonly 10 tablets per strip/box configuration may differ per packaging).

Storage Instructions
Store in a cool, dry place away from sunlight and moisture.

Precautions
Monitor liver function, avoid abrupt discontinuation, periodically check blood counts

Appearance
White to off-white round tablets

Contraindications
Known hypersensitivity to valproate, severe liver dysfunction, urea cycle disorders

Side Effects
May include nausea, tremor, lethargy, increased liver enzymes, weight gain

MRP (if applicable)
Variable (dependent on manufacturer and region)

Controlled Release Mechanism
Extended release for sustained therapeutic levels

ATC Code
N03AG01

Regulatory Status
Approved by Drug Controller General (India)

Route of Administration
Oral

Prescription Status
Prescription only

SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET Trade Information

Minimum Order Quantity
100 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Pieces Per Month

Sample Available
No

Packaging Details
10X10

Main Domestic Market
All India

About SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET

Genericart Sodium Valproate+Valproic Acid 333mg/145mg Tablet CR is a combination of two medicines used to treat epilepsy, a neurological disorder in which there are recurrent episodes of seizures or fits. It controls the abnormal activity of the brain, relaxes the nerves and hence, prevents seizures or fits.

Controlled Release for Steady Therapeutic Effect

This medication utilizes an extended-release mechanism, ensuring a consistent level of active ingredients in the bloodstream over time. By releasing Sodium Valproate and Valproic Acid gradually, it reduces dosing frequency and helps maintain stable control of symptoms with minimized peaks and troughs.

Indications and Recommended Usage

SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET is indicated for the treatment of epilepsy, seizure prevention, and bipolar disorder. Dosage is tailored by a physician based on each patient's clinical response. The tablets are suitable for adults and children above 12 years, and should only be taken under medical supervision.

Important Safety Precautions

Regular monitoring of liver function and blood counts is required during treatment. The medicine should not be discontinued suddenly without consulting a healthcare provider. Patients with severe liver dysfunction, urea cycle disorders, or known hypersensitivity to valproate should not use this product. Common side effects include nausea, tremor, and lethargy.

FAQ's of SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET:

Q: How should SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET be taken?

A: This medication should be swallowed whole, not crushed or chewed, preferably after meals to reduce gastric irritation. Always follow your physician's specific instructions for dosage and timing.

Q: What conditions are treated with this controlled release tablet?

A: It is indicated for managing epilepsy, preventing seizures, and as a mood stabilizer for bipolar disorder. The prescription must come from a healthcare professional, who will determine if it is appropriate for your condition.

Q: When should liver function and blood counts be monitored while using this medication?

A: Liver function tests and blood counts should be performed prior to starting therapy and then periodically during treatment, as recommended by your doctor, to monitor for potential side effects.

Q: Where should the tablets be stored to maintain their effectiveness?

A: Store the tablets in a cool, dry place away from sunlight and moisture. Always keep medications out of reach of children and do not use after the expiration date.

Q: What benefits does the controlled release mechanism offer?

A: The extended-release feature allows a gradual and prolonged release of medication, maintaining stable blood levels, improving symptom control, and potentially reducing side effects compared to immediate-release formulations.

Q: What are the main precautions and contraindications for this medication?

A: Major precautions include monitoring liver function and blood counts, and avoiding abrupt discontinuation. It is contraindicated in cases of known hypersensitivity to valproate, severe liver dysfunction, or urea cycle disorders.

Q: Who can use this medication and in what quantities is it typically available?

A: SODIUM VALPROATE 333 VALPROIC ACID CONTROLLED RELEASE 145 TABLET is prescribed for adults and children above 12 years, as directed by a physician. It is usually available in blister strips, typically with 10 tablets per strip, though packaging can vary by manufacturer.

Tell us about your requirement